Effects of hyperthermochemoradiotherapy on KSE-1 cells, a newly established human squamous cell line derived from esophageal carcinoma

H. Matsuok, K. Sugimachi, Masaki Mori, H. Kuwano, S. Ohno, S. Nakano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hyperthermia alone inhibits growth of the human esophageal cancer cell line (KSE-1). Even temporary exposure to hyperthermia results in substantial decreases in growth in a time- and temperature-dependent manner. A precipitous decrease in growth occurred at a temperature of approximately 42.5 °C. Concomitant application of hyperthermia, bleomycin and irradiation (hyperthermochemoradiotherapy, HCR) had a maximal effect on cell growth, compared to findings in cells treated with only one or two of these modalities. Fractionated hyperthermia (42 °C, 60 min) at a time interval of under 12 h was less effective than a single application (42 0 C, 120 min). However, over a 12-hour time interval, the effects of both treatments were similar. Fractionated HCR (hyperthermia: 42 °C, 60 min, chemotherapy: 2 ug/ml of bleomycin, 60 min, radiotherapy: 2 Gy) at a time interval of under 21 h was less effective than a single HCR (hyperthermia: 42 °C, 120 min, chemotherapy: 2 ug/ml of bleomycin, 120 min, radiotherapy: 4 Gy). We conclude that care should be taken regarding development of thermotolerance when combined modality therapy is given.

Original languageEnglish
Pages (from-to)49-59
Number of pages11
JournalEuropean Surgical Research
Volume21
Issue number1
DOIs
Publication statusPublished - Jan 1 1989

Fingerprint

Fever
Epithelial Cells
Carcinoma
Cell Line
Bleomycin
Growth
Radiotherapy
Drug Therapy
Combined Modality Therapy
Temperature
Esophageal Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Effects of hyperthermochemoradiotherapy on KSE-1 cells, a newly established human squamous cell line derived from esophageal carcinoma. / Matsuok, H.; Sugimachi, K.; Mori, Masaki; Kuwano, H.; Ohno, S.; Nakano, S.

In: European Surgical Research, Vol. 21, No. 1, 01.01.1989, p. 49-59.

Research output: Contribution to journalArticle

@article{8b36eb68f39b43ceb46d47b72bb610d2,
title = "Effects of hyperthermochemoradiotherapy on KSE-1 cells, a newly established human squamous cell line derived from esophageal carcinoma",
abstract = "Hyperthermia alone inhibits growth of the human esophageal cancer cell line (KSE-1). Even temporary exposure to hyperthermia results in substantial decreases in growth in a time- and temperature-dependent manner. A precipitous decrease in growth occurred at a temperature of approximately 42.5 °C. Concomitant application of hyperthermia, bleomycin and irradiation (hyperthermochemoradiotherapy, HCR) had a maximal effect on cell growth, compared to findings in cells treated with only one or two of these modalities. Fractionated hyperthermia (42 °C, 60 min) at a time interval of under 12 h was less effective than a single application (42 0 C, 120 min). However, over a 12-hour time interval, the effects of both treatments were similar. Fractionated HCR (hyperthermia: 42 °C, 60 min, chemotherapy: 2 ug/ml of bleomycin, 60 min, radiotherapy: 2 Gy) at a time interval of under 21 h was less effective than a single HCR (hyperthermia: 42 °C, 120 min, chemotherapy: 2 ug/ml of bleomycin, 120 min, radiotherapy: 4 Gy). We conclude that care should be taken regarding development of thermotolerance when combined modality therapy is given.",
author = "H. Matsuok and K. Sugimachi and Masaki Mori and H. Kuwano and S. Ohno and S. Nakano",
year = "1989",
month = "1",
day = "1",
doi = "10.1159/000129003",
language = "English",
volume = "21",
pages = "49--59",
journal = "European Surgical Research",
issn = "0014-312X",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Effects of hyperthermochemoradiotherapy on KSE-1 cells, a newly established human squamous cell line derived from esophageal carcinoma

AU - Matsuok, H.

AU - Sugimachi, K.

AU - Mori, Masaki

AU - Kuwano, H.

AU - Ohno, S.

AU - Nakano, S.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Hyperthermia alone inhibits growth of the human esophageal cancer cell line (KSE-1). Even temporary exposure to hyperthermia results in substantial decreases in growth in a time- and temperature-dependent manner. A precipitous decrease in growth occurred at a temperature of approximately 42.5 °C. Concomitant application of hyperthermia, bleomycin and irradiation (hyperthermochemoradiotherapy, HCR) had a maximal effect on cell growth, compared to findings in cells treated with only one or two of these modalities. Fractionated hyperthermia (42 °C, 60 min) at a time interval of under 12 h was less effective than a single application (42 0 C, 120 min). However, over a 12-hour time interval, the effects of both treatments were similar. Fractionated HCR (hyperthermia: 42 °C, 60 min, chemotherapy: 2 ug/ml of bleomycin, 60 min, radiotherapy: 2 Gy) at a time interval of under 21 h was less effective than a single HCR (hyperthermia: 42 °C, 120 min, chemotherapy: 2 ug/ml of bleomycin, 120 min, radiotherapy: 4 Gy). We conclude that care should be taken regarding development of thermotolerance when combined modality therapy is given.

AB - Hyperthermia alone inhibits growth of the human esophageal cancer cell line (KSE-1). Even temporary exposure to hyperthermia results in substantial decreases in growth in a time- and temperature-dependent manner. A precipitous decrease in growth occurred at a temperature of approximately 42.5 °C. Concomitant application of hyperthermia, bleomycin and irradiation (hyperthermochemoradiotherapy, HCR) had a maximal effect on cell growth, compared to findings in cells treated with only one or two of these modalities. Fractionated hyperthermia (42 °C, 60 min) at a time interval of under 12 h was less effective than a single application (42 0 C, 120 min). However, over a 12-hour time interval, the effects of both treatments were similar. Fractionated HCR (hyperthermia: 42 °C, 60 min, chemotherapy: 2 ug/ml of bleomycin, 60 min, radiotherapy: 2 Gy) at a time interval of under 21 h was less effective than a single HCR (hyperthermia: 42 °C, 120 min, chemotherapy: 2 ug/ml of bleomycin, 120 min, radiotherapy: 4 Gy). We conclude that care should be taken regarding development of thermotolerance when combined modality therapy is given.

UR - http://www.scopus.com/inward/record.url?scp=0024598825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024598825&partnerID=8YFLogxK

U2 - 10.1159/000129003

DO - 10.1159/000129003

M3 - Article

VL - 21

SP - 49

EP - 59

JO - European Surgical Research

JF - European Surgical Research

SN - 0014-312X

IS - 1

ER -